Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin-Reference-Cited by-同舟云学术

Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin

Published:2023-08 Issue:2 Volume:89 Page:283-292
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Kim Madeline,Del Duca Ester,Cheng Julia,Carroll Britta,Facheris Paola,Estrada Yeriel,Cha Amy,Werth John,Bissonnette Robert,Nocka Karl,Zang Chuanbo,Pavel Ana B.,Guttman-Yassky Emma

Funder

Pfizer Inc

Publisher

Elsevier BV

Subject

Dermatology

Reference72 articles.

1. Crisaborole and atopic dermatitis skin biomarkers: an intrapatient randomized trial;Bissonnette;J Allergy Clin Immunol,2019

2. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies;Brunner;J Allergy Clin Immunol,2017

3. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies;Eichenfield;J Am Acad Dermatol,2014

4. Management of difficult-to-treat atopic dermatitis;Arkwright;J Allergy Clin Immunol Pract,2013

5. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis;Beck;N Engl J Med,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical anti-inflammatory treatments for eczema: network meta-analysis;Cochrane Database of Systematic Reviews;2024-08-06

2. Proteomic alterations in patients with atopic dermatitis;Expert Review of Proteomics;2024-05-22

3. Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis;Dermatology and Therapy;2024-03-28

4. Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis;Acta Dermato-Venereologica;2023-08-22